Top compounds associated with response to SLC22A13

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	LE-135	CTRPv2	pan-cancer	AAC	0.033	0.4
mRNA	trifluoperazine	CTRPv2	pan-cancer	AAC	-0.035	0.4
mRNA	tanespimycin:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.029	0.4
mRNA	Methotrexate	GDSC1000	pan-cancer	AAC	-0.026	0.4
mRNA	Crizotinib	gCSI	pan-cancer	AAC	-0.049	0.4
mRNA	PHA-665752	CCLE	pan-cancer	AAC	0.042	0.4
mRNA	Zebularine	CTRPv2	pan-cancer	AAC	-0.031	0.4
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.033	0.4
mRNA	SL 0101-1	GDSC1000	pan-cancer	AAC	-0.031	0.4
mRNA	tivozanib	CTRPv2	pan-cancer	AAC	-0.033	0.4

Download CSV